Biologist Hood Uses Loose Reins To Guide 'Gang of 70'

Around the California Institute of Technology, members of Leroy Hood’s lab occasionally call themselves the “Gang of 70.” In fact, the precise number working for one of the world’s top biologists changes constantly with the natural ebb and flow of graduate students, postdoctorates, and technical staff. But the spirit of the nickname remains constant: Hood’s team is big, anywhere from eight to 10 times bigger than the typical academic lab team. However, the group m

Written byKathryn Phillips
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Around the California Institute of Technology, members of Leroy Hood’s lab occasionally call themselves the “Gang of 70.” In fact, the precise number working for one of the world’s top biologists changes constantly with the natural ebb and flow of graduate students, postdoctorates, and technical staff. But the spirit of the nickname remains constant: Hood’s team is big, anywhere from eight to 10 times bigger than the typical academic lab team. However, the group manages to buck the general criticism that big groups aren’t productive.

In a typical year, the team publishes 30 or more journal articles. But that, says Hood, is not the definitive measure of productivity. “I think what really counts is what you do that is new and significant and different,” Hood says. “That isn’t quantifiable by the numbers of papers. It’s quantifiable by the impact it [the teami has on the biological community.”

Using Hood’s standard, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies